baber/WOPTO huggingface dataset:
Patent ES-531340-A0 (ES)
IPC: D06P1/16
Filed: 1984-04-06
Abstract: 1. A process for the level dyeing of synthetic fibers with disperse dyestuffs, which comprises dyeing in the presence of a mixture which comprises ethoxylated unsaturated carboxylic acids of 12 to 18 carbon atoms and an ethylene oxide content of 10 to 40 units and sulfosuccinic acid half-esters of alkoxylated polynuclear alkylphenols of the general formula I  see diagramm : EP0121887,P6,F1 in which R denotes a radical  see diagramm : EP0121887,P6,F2  or  see diagramm : EP0121887,P6,F3  X denotes ethylene and/or propylene groups, and R1 denotes a saturated straight-chain or branched alkyl radical of 6 to 14 carbon atoms and in which Y represents hydrogen or has the same meaning as R, n represents numbers from 2 to 25, Z represents numbers from 1 to 9, and Me represents a hydrogen atom, an alkali metal atom or one equivalent of an alkaline earth metal atom.
Patent ES-546857-A0 (ES)
IPC: A61K31/00
Filed: 1985-08-14
Abstract: 1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE A 1-(aminophenyl)-2-aminopropanone derivative selected from the group consisting of : a) compounds of the general formula (I)   see diagramm : EP0174242,P25,F1   in which X is NH2 , Y is H or a halogen atom, Z is H or a halogen atom, R1 is C1 -C4 alkyl or C3 -C6 cycloalkyl and R2 is H or C1 -C4 alkyl or R1 and R2 , taken together, can form, with the nitrogen atom to which they are bonded, an N-heterocyclic group having from 5 to 7 ring members and which can be substituted, said NR1 R2 groups being selected from the group comprising the pyrrolidino, morpholino, thiomorpholino, piperidino, hexamethyleneimino, piperazino, 4-methylpiperazino and 4-(beta-hydroxyethyl)piperazino, 4-phenylpiperazino and 4-(p-chlorophenyl) piperazino groups ; and b) addition salts thereof. 1. Claims for the Contracting State : AT A method for the preparation of a 1-(aminophenyl)-2-aminopropanone derivative of the general formula : (I)   see diagramm : EP0174242,P26,F1   in which X is NH2 , is H or a halogen atom, Z is H or a halogen atom, R1 is C1 -C4 alkyl or C3 -C6 cycloalkyl and R2 is H or C1 -C4 alkyl, or R1 and R2 , taken together, can form, with the nitrogen atom to which they are bonded, an N-heterocyclic group having from 5 to 7 ring members and which can be substituted, said NR1 R2 groups being selected from the group consisting of the pyrrolidino, morpholino, thiomorpholino, piperidino, hexamethyleneimino, piperazino, 4-methylpiperazino and 4-(beta-hydroxyethyl)-piperazino, 4-phenylpiperazino and 4-(p-chlorophenyl) piperazino groups, and addition salts thereof, the said method comprising subjecting a 1-(acetylaminophenyl)-2-amino-propanone derivative of the formula : (II)   see diagramm : EP0174242,P26,F2   in which Y, Z, R1 and R2 are defined as indicated above, to a deacetylation reaction with an aqueous solution of HCI, for at least 0,25 hour, at the reflux temperature of the reaction medium, whereby 1 mol of compound II is used for 0,7 to 2 liters of 4 n HCI.
Patent ES-555987-A0 (ES)
IPC: C07D401/04
Filed: 1986-06-12
Abstract: The present invention provides a process for the preparation of herbicidal 2-(4,4-disubstituted-5-oxo-2-imidazolin-2-yl) benzoic, nicotinic and quinoline-3-carboxylic acids, esters and salts.
Patent ES-557604-A0 (ES)
IPC: C07D207/273
Filed: 1987-06-16
Abstract: Novel Substituted tetrahydro-, hexahydro- and octahydro-[3,4'-bi-2H-pyrrolel]-2,2'-diones of the formula    <IMAGE> (I)  in which each of R1 and R2 represents a carboxy-lower alkyl radical, or an unsubstituted carbamoyl-lower alkyl radical or a carbamoyl-lower alkyl radical which is N-mono- or N,N-di-substituted by lower alkyl, hydroxy-lower alkyl, lower alkoxy-lower alkyl, amino-lower alkyl, N-mono- or N,N-di-lower alkylamino-lower alkyl, or by N,N-alkyleneamino-lower alkyl optionally substituted (in the alkyleneamino radical) by lower alkoxycarbonyl and by oxo or hydroxy, or N,N-alkenylene-amino-lower alkyl optionally substituted (in the alkenyleneamino radical) by lower alkoxycarbonyl and optionally additionally by hydroxy, or N,N-(aza-, N'-lower alkylaza- or N'-lower alkanoylaza-, oxa- or thia)alkyleneamino-lower alkyl, each of which has from 4 to 8 ring members, carbamoyl-lower alkyl, N-mono- or N,N-di-lower alkylcarbamoyl-lower alkyl, 3- to 8-membered cycloalkyl, dicycloalkyl or tricycloalkyl, or by phenyl-lower alkyl which is unsubstituted or substituted in the phenyl moiety by lower alkyl, lower alkoxy, halogen and/or trifluoromethyl, or represents a carbomoyl-lower alkyl radical which is disubstituted by alkylene optionally substituted by lower alkoxycarbonyl and by oxo or hydroxy, or by alkenylene optionally substituted by lower alkoxycarbonyl and optionally additionally by hydroxy, or by aza-, N'-lower alkylaza- or N'-lower alkanoylaza-, oxa- or thia-alkylene, each of which has from 3 to 7 chain members, each of R3, R4, R5 and R6 represents hydrogen or lower alkyl, or R3 and R4 together and/or R5 and R6 together represent a 4- to 8-membered alkylene radical, and each of R7, R8, R9 and R10 represents hydrogen, or R7 together with R8 and/or R9 together with R10 represent in each case an additional bond, and their salts, have nootropic activity and can be used as active ingredients in medicaments. They are manufactured, for example, as follows: in a compound of the formula    <IMAGE> (IV)  in which R'1 represents a group that can be converted into a radical R1 and R'2 represents a radical R2 or a group that can be converted into the radical R2, or in a salt thereof, R'1 is converted into a group R1 and, optionally, a radical R'2 that can be converted into R2 is converted into a group R2.
Patent FI-830893-A0 (FI)
Inventor: NAGANO HIROYUKI
IPC: A61K31/495
Filed: 1983-03-17
Abstract: Phenylpiperazine derivatives of the formula:wherein R, is a hydrogen atom or a straight- or branched-chain saturated or unsaturated alkyl group having 1 to 8 carbon atoms which may be substituted at any position by a hydroxyl group, a carboxyl group, a lower alkoxycarbonyl group or an oxo group; and R<sub>2</sub> is a hydrogen atom, a halogen atom, a lower alkyl group or a sulfamoyl group; and a process for producing the same are disclosed. The derivatives of the formula have alpha blocking and serotonin antagonizing activities and are useful as a drug.
Patent FI-841308-A0 (FI)
Inventor: CARTER WILLIAM ALVIN
IPC: A24B15/36
Filed: 1984-04-02
Abstract: Methods and compositions are provided for preparing stabilized interferons and for combining stabilized interferon with cigarettes. Special domains of the interferon molecule are recognized by methods which are described. A means for constructing these domains by recombinant DNA technology is detailed. A method for stabilizing natural interferons is also described. A process for combining the stabilized interferon with cigarettes is presented. The combination of interferons and cigarettes is synergistic, especially because interferon effects are magnified at elevated temperatures and because interferon has a preferential effect on tumor cells, but for other reasons as well. The process is not obvious and will be beneficial to a large segment of mankind; those who use tobacco products.
Patent FI-852370-A0 (FI)
Inventor: LINCOLN JAY PERRY
IPC: A61L17/00
Filed: 1985-06-14
Abstract: A dispensing pack for needled sutures comprises a moulded plastics cover panel 1 hinged to a compartmented base panel 2 within which the or each suture 10 extends in a sinusoidal manner between the interconnected compartments 11. One or more needles are mounted in supports 7 to extend across a recess 9 in an end portion of panel 2, this end portion extending beyond the cover panel 1 after closure of the pack. Studs 12 on panel 2 engage in corresponding apertures of panel 1 to lock the panels 1 and 2 when closed.
Patent FI-864017-A0 (FI)
Inventor: SEIDELMANN DIETER
IPC: C07D471/04
Filed: 1986-10-03
Abstract: Compounds of formula I    <IMAGE>  (I)  wherein R1 is hydrogen or a protecting group, R2 is -CH=CR24 or -C 3BOND CR4, R4 is hydrogen or halogen, R3 is hydrogen, lower alkyl or lower alkoxyalkyl, RA is, inter alia, hydrogen, OR7, lower alkyl, which optionally is substituted with aryl, lower alkoxy or NR5R6, R5 and R6 can be the same or different and in each case is hydrogen, lower alkyl or together with the nitrogen atom a 5-6 member ring, which can contain another heteroatom, R7 is lower alkyl, optionally substituted aryl or aralkyl, and each compound can contain one or more RA radicals which are not hydrogen, have valuable pharmacological properties.
Patent FI-872675-A0 (FI)
Inventor: BOYLE FRANCIS THOMAS
IPC: C07D249/08
Filed: 1987-06-16
Abstract: Heterocyclic compounds of the formula:- <CHEM> wherein X and Y, which may be the same or different, are each a =N- or =CH- group and R is a phenyl radical which optionally bears one or more substituents selected from halogen atoms, amino, cyano, carbamoyl, hydroxy and nitro radicals, 1-6C alkyl, halogenoalkyl, alkoxy, halogenoalkoxy and alkylamino radicals, di(1-6C alkyl)amino and 2-6C alkoxycarbonyl radicals, and n is 1 to 6, but excluding the compound wherein X and Y are each =N-, R is 2,4-dichlorophenyl and n is 1; and the pharmaceutically or veterinarily acceptable acid addition salts thereof; processes for their manufacture; and pharmaceutical and veterinary compositions containing them.
Patent FI-884276-A0 (FI)
Inventor: APPLEBAUM JOY D
IPC: C12N15/00
Filed: 1988-09-16
Abstract: A synthetic gene encoding a 71-amino acid analog of human insulin-like growth factor (hIGF-I) has been constructed and expressed in the yeast, Saccharomyces cerevisiae. The protein analog, IGF132, contains the first 17 amino acids of the B chain of human insulin in place of the first 16 amino acids of hIGF-I. The purified hybrid protein has high affinity for the type I IGF receptor (12 nM) yet has drastically reduced affinity for human serum carrier proteins (>1000 nM). This analog is 5 to 10 times more active than normal hIGF-I in stimulating DNA synthesis in 3T3 cells and is a more active growth factor in vivo due to its reduced affinity for serum carrier proteins. Other proteins with similar properties have also been constructed. The protein analogs thus have a variety of utilities such as in promoting lactation in animals; promoting growth and feed efficiency in animals; improving carcass quality by increasing lean and decreasing fat; promoting wound healing in animals, including humans; promoting glucose utilization in skeletal muscle, and stimulating erythropoiesis, the production of red blood cells.
Patent FI-885627-A0 (FI)
Inventor: AUPIC BERNARD
IPC: B29C65/74
Filed: 1988-12-02
Abstract: The method for end-to-end joining of the edges of a rubberised fabric formed from reinforcing elements which are parallel to each other and separated by a distance p, consists in injecting, under pressure and hot, between the reinforcing elements of the edges separated by a distance having a value d greater than 1.5 p, a rubber mix having cohesion and green strength properties superior to the same properties of the mix embedding the reinforcing elements. In the pneumatic tyre produced from a single fabric, the joining mix has a tensile modulus of elasticity greater than the same modulus of the mix embedding the reinforcing elements of the radial-ply carcass strengthening. 
<IMAGE>
Patent FI-902672-A0 (FI)
Inventor: LINDBERG SVEN
IPC: F41A3/74
Filed: 1990-05-29
Abstract: The disclosure relates to a breech mechanism for large-calibre guns such as artillery pieces being characterized by a specifically designed sealing function in the form of an intermediate layer between the mechanism breech (4) proper and a seating portion (7) displaceable in relation thereto by the gas pressure in the gun, the seating portion, on being displaced towards the breech (4), compressing the intermediate layer (8) disposed therebetween and consisting of an elastically deformable refractory material which, on its deformation, is urged into tight abutment against the rear portion of the gun barrel about the loading space of the gun along a gap between the seating portion (7) and the mechanism breech (4) proper.
Patent FI-902850-A0 (FI)
Inventor: EFFLAND RICHARD CHARLES
IPC: A61K31/7042
Filed: 1990-06-07
Abstract: This invention relates to a N-heteroaryl-purin-6-amine of the formula   <CHEM> where R1 is hydrogen, lower alkyl, and arylloweralkyl; R2 and R3 are independently hydrogen, lower alkyl or R2 and R3 taken together are aryl; R4 and R5 are independently hydrogen, lower alkyl, or R4 and R5 taken together are aryl; R6 is hydrogen, lower alkyl, aryl, arylloweralkyl, <CHEM> where R2, R3, R4 and R5 are as defined above, and the pharmaceutically acceptable acid addition salts thereof and where applicable the geometric and optical isomers and racemic mixtures thereof. The compounds of this invention display utility as analgesic and anticonvulsant agents.
Patent FI-904805-A0 (FI)
Inventor: EDLER BERND
IPC: H04B1/66
Filed: 1990-09-28
Abstract: PCT No. PCT/EP90/00143 Sec. 371 Date Oct. 1, 1990 Sec. 102(e) Date Oct. 1, 1990 PCT Filed Jan. 26, 1990 PCT Pub. No. WO90/09063 PCT Pub. Date Aug. 9, 1990.Transmitting a signal wherein the signals is segmented by means of windows into successive overlapping blocks, the partial signals contained in the blocks are converted by transformation into a spectrum, with the spectra then being coded, transmitted, decoded after transmission and converted back into partial signals by retransformation. Finally, the blocks containing the partial signals are joined in an overlapping manner, with the overlapping regions of the blocks being weighted such that the resultant of the window functions in the respective overlapped regions equals one. To 2.2. In order to avoid interferences in adjacent blocks upon changes in the signal amplitude, the length of the window functions is selected as a function of signal amplitude changes. The method is suitable for the treatment of audio and video signals which are subjected to data reduction during transmission.
Patent FI-912320-A0 (FI)
Inventor: BARBI GIAMPAOLO
IPC: C08K9/04
Filed: 1991-05-13
Abstract: Nonextruded concentrates in particle form, each particle comprising:     A) a matrix consisting of a nonextruded particle of an olefin polymer or copolymer, having a porosity, expressed in percentage of voids on the volume of the particle, higher than or equal to 15%; B) one or more additives, pigments or fillers, or combinations thereof, deposited on the surface of the matrix (A) and/or inside its pores. The concentrates are used in the processing of polyolefins. n
Patent FI-913037-A0 (FI)
Inventor: BALSCHMIDT PER
IPC: A61K9/107
Filed: 1991-06-20
Abstract: Human insulin analogues having a positively charged amino acid residue, i.e. Lys or Arg, in position B28, i.e. in position 8 in the B-chain calculated from [Gly<sup>B20</sup>], and optionally being further modified in the C-terminal end of the B-chain from [Phe<sup>B24</sup>] to the C-terminal amino acid residue and optionally A21 and/or B3 being different from Asn as well as insulin preparations containing the human insulin analogues are provided.
Patent FI-934438-A0 (FI)
Inventor: VALKIRS GUNARS EDWIN
IPC: G01N33/53
Filed: 1993-10-08
Abstract: Novel conjugates and competitive and non-competitive assays for simultaneously detecting the presence or amount of at least two target ligands capable of competing with a single conjugate for binding to at least two different ligand receptors. The invention teaches and claims binding domains coupled to a signal development element to form a conjugate where each binding domain comprises at least one ligand analogue or ligand receptor depending on assay design. The binding domains are constructed such that they function independently from one another in assays for their respective target ligands. Each binding domain may bind its respective binding partners in the assay without affecting the binding reactions of other binding domains coupled to the same signal development element.
Patent FI-942202-A0 (FI)
Inventor: COATES GEORGE J
IPC: F16K5/06
Filed: 1994-05-11
Abstract: A spherical rotary valve assembly for an internal combustion engine of the piston and cylinder type wherein the spherical rotary valve assembly is positioned within a split cylinder head having an upper and lower section (110,112) such that when secured defines cavities (113) for a rotational shaft having mounted thereon, an intake drum (10) and an exhaust drum (40) for each cylinder, the lower half of the split head having an inlet port (108) and an outlet port (109) in communication with each cylinder, the cylinder head having an intake passageway and an exhaust passageway in communication with the drum cavities in the split cylinder head, the split cylinder head having reservoir cavities positioned adjacent the intake drum and exhaust drum, the intake drum being fed from both sides of the intake drum for the introduction and interruption of fuel/air mixture into the cylinder, the exhaust drum being evacuated from both sides of the exhaust drum thereby evacuating and interrupting the evacuation of exhaust gases from the cylinder, the intake drum and exhaust drum rotating within the cavities and a gas-tight sealing rotation on an annular sealing means (116) actually positioned about the inlet port and outlet port of the lower section of the split head assembly, respectively. <IMAGE>
Patent FI-952700-A0 (FI)
Inventor: LIDEN JAN GEORG
IPC: D21C11/00
Filed: 1995-06-02
Abstract: PCT No. PCT/SE93/01028 Sec. 371 Date Jun. 5, 1995 Sec. 102(e) Date Jun. 5, 1995 PCT Filed Nov. 29, 1993 PCT Pub. No. WO94/12723 PCT Pub. Date Jun. 9, 1994When producing green liquor for later manufacture of cooking liquor, it is endeavoured that the green liquor shall be readily clarified and/or readily filtered. This endeavour is achieved with the present invention, which relates to a method of producing green liquor in which waste liquor separated from cellulose pulp and derived from a cooking stage and possibly from one or more bleaching stages is worked up including known treatment stages such as evaporation, combustion, smelt dissolving and other green liquor preparation, and in which a calcium containing chemical is added to the waste liquor prior to combustion, or is added at the combustion of the waste liquor. The method is characterized in that carbon deriving from the smelt is caused to equal at most 0.3 weight promillage, calculated on the smelt after combustion, when and after dissolving the smelt in liquid; and in that the addition of calcium is controlled so that the amount of calcium added together with the amount of calcium that is already present will equal at least +E,fra 3/4+EE  of the amount of magnesium present in the waste liquor calculated in mol; and in that the addition is at most 10% by weight of the sodium plus sulphur present in the waste liquor.
Patent FI-962126-A0 (FI)
Inventor: EISEN NORBERT
IPC: C08G18/08
Filed: 1996-05-20
Abstract: PCT No. PCT/EP94/03688 Sec. 371 Date May 15, 1996 Sec. 102(e) Date May 15, 1996 PCT Filed Nov. 9, 1994 PCT Pub. No. WO95/14730 PCT Pub. Date Jun. 1, 1995Rigid foams which possess urethane groups are prepared by reacting polyisocyanates with compounds which possess at least two active hydrogen atoms which are reactive towards isocyanate groups, in the presence of water and alkanes as blowing agent and solution promoters. The solution promoter used is a compound with a polar group.
Patent FI-982653-A0 (FI)
Inventor: SAERELAE ANTTI
IPC: G05B9/02
Filed: 1998-12-08
Abstract: The invention relates to an arrangement in connection with a feedback control system, the arrangement comprising a controllable device ( 10 ), a measuring device ( 7 ), a controlling device ( 9 ) and a user interface by which the controlling device ( 9 ) can be monitored by means of set values. The measuring device ( 7 ) is adapted to measure a measuring value ( 8 ) from a measuring point, which measuring value is dependent on the operation of the controllable device and the controlling device ( 9 ) is adapted to monitor the controllable device ( 10 ) on the basis of the measuring value and set values. To improve safety, the arrangement comprises means ( 15 a, 15 b, 15 c) adapted to feed a reference signal ( 16 ) to the measuring device ( 7 ) periodically. The controlling device ( 9 ) is adapted to compare a measuring value ( 18 ) obtained from the reference signal with the real reference value ( 17 ) of the reference signal and adapted to take a safety measure when the measuring value ( 18 ) and the real reference value ( 17 ) differ substantially from each other.
Patent IL-61148-A0 (IL)
Title: Phosphonium salts and pesticidal compositions containing them
IPC: C07F9/54
Filed: 1980-09-28
Abstract: Tri(phenyl)alkyl phosphonium halides wherein the phenyl groups contain a long chain or sterically hindered alkyl group are novel and exhibit efficacious levels of fungicidal and bacteriocidal activity. The presence of the alkyl substituent eliminates or significantly reduces the phytotoxicity that characterizes the corresponding unsubstituted phosphonium compounds.
Patent IL-65822-A0 (IL)
Title: Process for the preparation of dimedone
IPC: C07C45/45
Filed: 1982-05-19
Abstract: Process for the production of dimedone from isophorone. The isophorone is converted in the presence of a solvent with ozone into an ozone-addition product. An alcohol corresponding to the ester radical is added at the latest after the formation of the ozone-addition product for the formation of the intermediate product, 3,3-dimethyl-5-oxo-hexanoic acid ester. The ozone addition product is heated in the presence of acids to a temperature of 20 DEG  to 150 DEG  C. The 3,3-dimethyl-5-oxo-hexanoic acid ester is isolated thereby. The ester is then converted in a further step into dimedone by treatment of the ester with an alkali alcoholate in an anhydrous milieu.
Patent IL-67938-A0 (IL)
Title: Substituted oximinoacetanilides,their preparation and their use as pesticides
IPC: C07C67/00
Filed: 1983-02-17
Abstract: Substituted oximinoacetanilides of the general formula    <IMAGE> (I)  in which R1 denotes an alkyl or alkoxy group or a halogen atom, R2 denotes a hydrogen or halogen atom or an alkyl or trifluoromethyl group, R3 denotes a hydrogen or halogen atom or an alkyl group, R4 denotes a hydrogen atom or a methyl group, R5 denotes an alkoxy, amino or -NH-CO-NH-R7 group, wherein R7 represents a hydrogen atom or an optionally cyano-, alkoxy- or alkoxycarbonyl-substituted alkyl group, or represents a cycloalkyl group, and R6 denotes various aliphatic or heterocyclic radicals, are new and find use as pest-combating agents, in particular as fungicides.
Patent IL-75247-A0 (IL)
Title: Composition and process for conditioning the surface of plastic substrates prior to metal plating
IPC: H05K3/00
Filed: 1985-05-20
Abstract: An alkaline composition for enhancing the adhesiveness of metal plating to a plastic substrate comprising: (a) a compound represented by general formula (I), and (b) a compound represented by general formula (II), wherein R1, R2, R3, and R4 are independently selected from the group consisting of hydrogen atoms, aryl groups and alkyl groups of 1-4 carbon atoms, m is 0 to 2 and n is 2 to 5; the compositions comprising, by weight, about 10 gram/liter (g/l) to saturation compound (a) and about 10g/l to saturation compound (b). The composition is preferably employed before alkaline permanganete etching of the plastic, followed by electroless metal plating using conventional techniques.
Patent IL-90019-A0 (IL)
Title: Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having improved core membrane adhesion properties
IPC: A61K9/52
Filed: 1989-04-18
Abstract: The present invention relates to an oral osmotic system for the control and continuous administration of metoprolol over a lengthy time interval, which contains a uniform, separate internal layer of water-soluble coating agent. Water-soluble coating agents which can be used are HPMC, PVP, optionally mixed with polyethylene glycol.